SSTR3 and neoplasm: Furthermore, regarding SSTRs, SSTR3 ligands could be a very interesting druggable target in NF-PitNETs and its pharmacologic activation may be of potential benefits regarding the prevention of tumor regrowth, since SSTR3 inhibits cell cycle dynamics and promotes apoptosis.